FONTENOT v. AUROBINDO PHARMA, LTD. et al
| PATRICK FONTENOT |
| HETERO DRUGS, LTD., AUROBINDO PHARMA, LTD., JOHN DOE, HETERO LABS, LTD., MYLAN N.V., ZHEJIANG HUABAI PHARMACEUTICAL CO., LTD, MYLAN LABORATORIES LTD., MCKESSON CORPORATION, NUCARE PHARMACEUTICALS, INC., THE HARVARD DRUG GROUP, LLC, AUROLIFE PHARMA, LLC, REMEDYREPACK, INC., TEVA PHARMACEUTICALS USA, INC., ACTAVIS LLC, H J HARKINS CO., INC., CARDINAL HEALTH, INC., ACTAVIS PHARMA, INC., MYLAN PHARMACEUTICALS INC., TORRENT PHARMACEUTICALS, LTD., PREFERRED PHARMACEUTICALS, INC., BRYANT RANCH PREPACK, INC., HUAHAI U.S. INC., HETERO USA, INC., CAMBER PHARMACEUTICALS, INC., AMERISOURCEBERGEN CORPORATION, PRINSTON PHARMACEUTICAL INC., NORTHWIND PHARMACEUTICALS, SOLCO HEALTHCARE U.S., LLC, ARROW PHARM (MALTA) LTD., A-S MEDICATION SOLUTIONS, LLC, AUROBINDO PHARMA USA, INC., AVKARE, INC., WALMART INC., ACETERIS, LLC, TORRENT PHARMA, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD. and ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. |
| VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION |
| 1:2020cv00050 |
| January 2, 2020 |
| US District Court for the District of New Jersey |
| Robert B Kugler |
| Joel Schneider |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 3, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 2 SUMMONS ISSUED as to A-S MEDICATION SOLUTIONS, LLC, ACETERIS, LLC, ACTAVIS LLC, ACTAVIS PHARMA, INC., AMERISOURCEBERGEN CORPORATION, ARROW PHARM (MALTA) LTD., AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, AVKARE, INC., BRYANT RANCH PREPACK, INC., CAMBER PHARMACEUTICALS, INC., CARDINAL HEALTH, INC., H J HARKINS CO., INC., HETERO DRUGS, LTD., HETERO LABS, LTD., HETERO USA, INC., HUAHAI U.S. INC., MCKESSON CORPORATION, MYLAN LABORATORIES LTD., MYLAN N.V., MYLAN PHARMACEUTICALS INC., NORTHWIND PHARMACEUTICALS, NUCARE PHARMACEUTICALS, INC., PREFERRED PHARMACEUTICALS, INC., PRINSTON PHARMACEUTICAL INC., REMEDYREPACK, INC., SOLCO HEALTHCARE U.S., LLC, TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC., THE HARVARD DRUG GROUP, LLC, TORRENT PHARMA, INC., TORRENT PHARMACEUTICALS, LTD., WALMART INC., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (cry, ) |
| CLERK'S QUALITY CONTROL MESSAGE - The case you electronically filed has been processed, however, the following deficiencies were found: Nature of Suit, Parties listed on docket do not match parties on complaint, In the future when choosing parties please choose each party individually. Do not select "all plaintiffs" or "all defendants." . The Clerk's Office has made the appropriate changes. Please refer to the Attorney Case Opening Guide for processing electronically filed cases. (cry, ) |
| Member Case Direct File on 1/2/2019, for MDL 2875 VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION. (cry, ) |
| For all Case Management Orders #click here (cry, ) |
| Filing 1 COMPLAINT against All Defendants ( Filing and Admin fee $ 400 receipt number 0312-10218916), filed by PATRICK FONTENOT.(ROOT, RICHARD) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
